Intersections of vitamin D deficiency, <scp>HIV</scp> and chronic liver diseases
The intersection of HIV, MASLD, and vitamin D deficiency is biologically plausible and clinically relevant yet underexplored. Longitudinal studies with standardized MASLD phenotyping and vitamin D assessment are warranted. Meanwhile, integrating metabolic risk assessment with vitamin D evaluation may support more holistic liver care in people with HIV, while interventional trials should clarify whether vitamin D optimization improves hepatic and extrahepatic outcomes.
Authors
- Sahar Saeed (ORCID: https://orcid.org/0000-0002-0224-379X)
- Giovanni Guaraldi (ORCID: https://orcid.org/0000-0002-5724-3914)
- Angana Datta
- Bertrand Lebouché (ORCID: https://orcid.org/0000-0002-1273-9393)
- Francesca Farina (ORCID: https://orcid.org/0000-0003-4336-4325)
- Suzanne N. Morin (ORCID: https://orcid.org/0000-0002-4317-492X)
- Salvatore Petta (ORCID: https://orcid.org/0000-0002-0822-9673)
- Giada Sebastiani (ORCID: https://orcid.org/0000-0003-2655-8283)
Institutions
- University of Modena and Reggio Emilia (IT)
- Vita-Salute San Raffaele University (IT)
- Queen's University (CA)
- McGill University Health Centre (CA)
- University of Palermo (IT)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-09-20
- DOI
- https://doi.org/10.1111/hiv.70117
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00